0001209191-23-004300.txt : 20230120 0001209191-23-004300.hdr.sgml : 20230120 20230120170855 ACCESSION NUMBER: 0001209191-23-004300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221108 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Andrew Kenneth William CENTRAL INDEX KEY: 0001304113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 23541759 MAIL ADDRESS: STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC. STREET 2: 41 UNIVERSITY DRIVE CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-08 0 0001557746 Aclaris Therapeutics, Inc. ACRS 0001304113 Powell Andrew Kenneth William C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200 WAYNE PA 19087 1 0 0 0 Common Stock 2022-11-08 5 G 0 E 4000 0.00 D 9856 D /s/ Mark Ballantyne, Attorney-in-Fact 2023-01-20